Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica.


Journal article


B. Antiochos
Journal of the American Medical Association (JAMA), 2022

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Antiochos, B. (2022). Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica. Journal of the American Medical Association (JAMA).


Chicago/Turabian   Click to copy
Antiochos, B. “Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica.” Journal of the American Medical Association (JAMA) (2022).


MLA   Click to copy
Antiochos, B. “Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica.” Journal of the American Medical Association (JAMA), 2022.


BibTeX   Click to copy

@article{b2022a,
  title = {Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica.},
  year = {2022},
  journal = {Journal of the American Medical Association (JAMA)},
  author = {Antiochos, B.}
}


Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in